EUVIMEDEUVIMED entdecken
Open Access

Tumor microbiome-transcriptome crosstalk identifies Prevotella as an immunotherapeutic predictor in NSCLC

Na Wang, Lifang Ma, Yugang Huang, Xionghui Zhou, Yuan Rong, Fei Long, Wanbo Qiu, Si Wu, Yue Hu, Xin He, Jiurong He, Sufang Tian und 3 weitere

Theranostics · 2026

DOI: 10.7150/thno.126091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Na Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Renmin Hospital of Wuhan University, Wuhan 430060, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Microbiota, Transcriptome. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsMicrobiotaTranscriptomePrevotellaHumansImmunotherapyPrognosisTumor MicroenvironmentFemaleImmune Checkpoint InhibitorsMaleMiddle Aged

Stichwörter der Autor:innen

NSCLCPrevotellaimmunotherapy responsemicrobiometranscriptome

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Pathology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Department of Clinical Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
  • Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
  • College of Informatics, Huazhong Agricultural University, Wuhan 430070, China.
  • Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
  • Department of Thoracic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.

Zitieren

APA

Wang, N., Ma, L., Huang, Y., Zhou, X., Rong, Y., Long, F., Qiu, W., Wu, S., Hu, Y., He, X., He, J., Tian, S., Hu, W., Yuan, C., & Wang, F. (2026). Tumor microbiome-transcriptome crosstalk identifies Prevotella as an immunotherapeutic predictor in NSCLC. Theranostics. https://doi.org/10.7150/thno.126091

Vancouver

Wang N, Ma L, Huang Y, Zhou X, Rong Y, Long F, et al. Tumor microbiome-transcriptome crosstalk identifies Prevotella as an immunotherapeutic predictor in NSCLC. Theranostics. 2026. doi:10.7150/thno.126091

BibTeX
@article{Wang2026,
  author = {Wang, Na and Ma, Lifang and Huang, Yugang and Zhou, Xionghui and Rong, Yuan and Long, Fei and Qiu, Wanbo and Wu, Si and Hu, Yue and He, Xin and He, Jiurong and Tian, Sufang and Hu, Weidong and Yuan, Chunhui and Wang, Fubing},
  title = {Tumor microbiome-transcriptome crosstalk identifies Prevotella as an immunotherapeutic predictor in NSCLC},
  journal = {Theranostics},
  year = {2026},
  doi = {10.7150/thno.126091}
}
Kostenlos starten →